Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge

COVID-19 measures also suppress flu—for now

(2021) Kelly Servick   SCIENCE

Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model

(2021) Wen-Chun Liu et al.   Vaccines

Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin

(2021) Bo Ryoung Park et al.   Scientific Reports

Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis

(2021) George N Okoli et al.   Open Forum Infectious Diseases

A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats

(2021) Daria Mezhenskaya et al.   Biomedicines

Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses

(2021) Yo Han Jang et al.   Vaccines

Next-generation influenza vaccines: opportunities and challenges

(2020) Chih-Jen Wei et al.   NATURE REVIEWS DRUG DISCOVERY

Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research

(2020) Irina Kiseleva et al.   Viruses-Basel

Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections

(2020) Irina Isakova-Sivak et al.   Vaccines

Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens

(2020) Anna Kirsteina et al.   Vaccines

Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses

(2020) Victoria Matyushenko et al.   ANTIVIRAL RESEARCH

The Role of M2e in the Development of Universal Influenza Vaccines

(2019) Xavier Saelens   JOURNAL OF INFECTIOUS DISEASES

Recombinant influenza A viruses as vaccine vectors

(2019) Thomas Gerlach et al.   Expert Review of Vaccines

Influenza and Antibody-Dependent Cellular Cytotoxicity

(2019) Tarra A. Von Holle et al.   Frontiers in Immunology

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge

(2019) Irina Isakova-Sivak et al.   Vaccines

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

(2019) Tatiana Kotomina et al.   ANTIVIRAL RESEARCH

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

(2018) A Danielle Iuliano et al.   LANCET

Immune responses after live attenuated influenza vaccination

(2018) Kristin G.-I. Mohn et al.   Human Vaccines & Immunotherapeutics

Models for predicting the evolution of influenza to inform vaccine strain selection

(2018) Joseph K. Agor et al.   Human Vaccines & Immunotherapeutics

Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site

(2018) Tatiana Kotomina et al.   Human Vaccines & Immunotherapeutics

Extreme heterogeneity of influenza virus infection in single cells

(2018) Alistair B Russell et al.   eLife

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine

(2018) Daniil Korenkov et al.   Expert Review of Vaccines

Is It Possible to Develop a “Universal” Influenza Virus Vaccine?

(2017) Florian Krammer et al.   Cold Spring Harbor Perspectives in Biology

Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled Compounds

(2016) Eleonore Fröhlich et al.   Frontiers in Pharmacology

Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus

(2015) Tadaki Suzuki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Universal Influenza Vaccines: To Dream the Possible Dream?

(2015) Jae-Keun Park et al.   ACS Infectious Diseases

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells

(2015) Venkateswara R. Simhadri et al.   PLoS One

Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination

(2014) Yu-Na Lee et al.   IMMUNOLOGY

Evaluation of the Humoral and Cellular Immune Responses Elicited by the Live Attenuated and Inactivated Influenza Vaccines and Their Roles in Heterologous Protection in Ferrets

(2013) Xing Cheng et al.   JOURNAL OF INFECTIOUS DISEASES

Modification of the Ferret Model for Pneumonia From Seasonal Human Influenza A Virus Infection

(2012) J. M. A. van den Brand et al.   VETERINARY PATHOLOGY

The ferret as a model organism to study influenza A virus infection

(2011) J. A. Belser et al.   Disease Models & Mechanisms

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2)

(2011) Irina Isakova-Sivak et al.   VIROLOGY

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective

(2010) M. De Filette et al.   JOURNAL OF GENERAL VIROLOGY

Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis

(2009) Yuki Furuse et al.   Virology Journal

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

(2008) R WANG et al.   ANTIVIRAL RESEARCH

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

(2007) James W. Huleatt et al.   VACCINE